“Prevention of structural perturbation and aggregation of hepatitis B surface antigen: screening of various additives”

References

• Raghavendra C, Mundargi V, Babu R, Rangaswamy V, Patel, P, Tejraj MA. Nano/micro technologies for delivering macromolecular therapeutics using poly(d,l-lactide-co-glycolide) and its derivatives. J. Cont. Rel. 2008; 125: 193–209.
   PubMed Web of Science ®Google Scholar
• Banga A. Therapeutic Peptide and protein formulation, processing and delivery system. Technoic Lamester USA 1995; 131–163.
   Google Scholar
• Krishnamurthy R, Lumpkin JA, Sridhar R. Inactivation of Lysozyme By sonication under condition relevant to microencapsulation. Int. J. Pharm. Res. 2000; 18: 1754–1759.
   Google Scholar
• Bharali DJ, Mousa SA, Thanavala Y. Micro- and nanoparticle-based vaccines for hepatitis B. Adv. Exp. Med. Bio. 2007; 601: 415–421.
   PubMed Web of Science ®Google Scholar
• Jiang W, Gupta, R.K, Deshpande MC, Schwendeman SP. Biodegradable poly(lactic-co-glycolic acid) microparticles for injectable delivery of vaccine antigens. Adv. Dr. Del. Rev. 2005; 57: 391–410.
   PubMed Web of Science ®Google Scholar
• Bilati U, Allemann E, Doellkar E. Strategic approaches for overcoming peptide and protein stability with in biodegradable nano and microparticles. Euro. J. Pharm. 2005; 59: 375–388.
   Web of Science ®Google Scholar
• Amorij JP, Saluja V, Petersen AH, Hinrichs WLJ, Huckriede A, Frijlink HW. Pulmonary delivery of an inulin-stabilized influenza subunit vaccine prepared by spray-freeze drying induces systemic, mucosal humoral as well as cell-mediated immune responses in BALB/c mice. Vaccine, 2007; 2: 8707–8717.
   Web of Science ®Google Scholar
• Raghuvanshi RS, Goyal S, Singh Om Panda, AK. Stabilization of dichloromethane-induced protein denaturation during microencapsulation. Pharm. Dev. Technol. 1998; 3: 269–276.
   PubMedGoogle Scholar
• Perez C, Montano N, Gonzalez K, Griebenow K. Stabilization of alpha-chymotrypsin at the CH2Cl2/water interface and upon water-in-oil-in-water encapsulation in PLGA microspheres. J. Cont. Rel. 2003; 89: 71–85.
   PubMed Web of Science ®Google Scholar
• Jaganathan KS, Vyas SP. Strong systemic and mucosal immune responses to surface-modified PLGA microspheres containing recombinant Hepatitis B antigen administered intranasally. Vaccine, 2006; 24(19): 4201–4211.
   PubMed Web of Science ®Google Scholar
• Sah HK, Toddywala R, Chien YW. Biodegradable microcapsules prepared by a w/o/w-technique: effects of shear force to make a primary w/o emulsion on their morphology and protein release. J. Microencap. 1995; 12: 56–69.
   Web of Science ®Google Scholar
• Sah H. Stabilization of proteins against methylene chloride/water interface-induced denaturation and aggregation. J. Contr. Rel. 1999; 58: 143–151.
   PubMed Web of Science ®Google Scholar
• Uchida T, Shiosaki K, Nakada Y, Fukada K, Eda Y, Tokiyoshi S, Nagareya N, Matsuyama K. Microencapsulation of hepatitis B core antigen for vaccine preparation. Pharm. Res. 1998;15:1708–1713
   PubMed Web of Science ®Google Scholar
• Ingrid Castellanos J, Ruben C, Kai G. Encapsulation-induced aggregation and loss in activity of (-chymotrypsin and their prevention. J. Cont. Rel. 2002; 81: 307–319.
   PubMed Web of Science ®Google Scholar
• Ingrid Castellanos J, Wanda L, Cuadrado Kai G. Prevention of structural perturbations and aggregation upon encapsulation of bovine serum albumin into poly(lactide-co-glycolide) microspheres using the solid-in-oil-in-water technique. J. Pharm. Pharmacol. 2001; 53: 1099–1107.
   PubMed Web of Science ®Google Scholar
• Carrasquillo KG, Cordero RA, HO S, Franquiz JM, Griebenow K.. Structure-guided encapsulation of bovine serum albumin in poly(DL-lactic-co-glycolic)acid. Pharm. Pharmacol. Commun. 1998; 4: 563–571.
   Google Scholar
• McGee JP, Singh M, Li XM, Qiu H, Hagan O. The encapsulation of a model protein in poly(D,L lactide-co-.glycolide) microparticles of various sizes: an evaluation of preservation of process reproducibility. J. Microencap. 1997; 14: 197–210.
   PubMed Web of Science ®Google Scholar
• Cuervo ML, Sterling AL, Nicot IA, Rodríguez MG, García OR. Validation of a new alternative for determining in vitro potency in vaccines containing Hepatitis B from two different manufacturers. Biologicals 2008; 36(6): 375–382.
   PubMed Web of Science ®Google Scholar
• Morlock M, Koll H, Winter G, Kissel T. Microencapsulation of rh-erythropoietin, using biodegradable poly (DL-lactide-co-glycolide): protein stability and the effects of stabilizing excipients. Eur. J. Pharm. Biopharm. 1997; 43: 29–36.
   Web of Science ®Google Scholar
• Feng L, Qi XR, Zhou XJ, Maitani Y, Wang SC, Yang J, Nagai T. Pharmaceutical and immunological evaluation of a single-shot hepatitis B vaccine using PLGA microspheres. J. Cont. Rel. 2006; 112 (2): 35–42.
   PubMed Web of Science ®Google Scholar
• Hagan Derek TO, Singh M, Gupta RK. Poly (lactide-co-glycolide) microparticles for the development of single-dose controlled-release vaccines. Adv. Dr. Del. Rev. 1998; 32: 225–246.
   PubMed Web of Science ®Google Scholar
• Jilie K, Shaoning YU. Fourier Transform Infrared Spectroscopic Analysis of Protein Secondary Structures. Act. Biochim. Biophys. Sin. 2007; 39: 549–559.
   PubMed Web of Science ®Google Scholar
• Griebenow K, Santos AM, Carrasquillo KG. Secondary structure of proteins in the amorphous dehydrated state probed by FTIR spectroscopy. Dehydration-induced structure al changes and their prevention. Internet J. Vibr. Spec. [www.ijvs.com] 1999; 3(1): 3–11.
   Google Scholar
• Kelly M, Sharon J, Thomas J, Price NC. How to study proteins by circular dichorism. Biochim. Biophy. Act. 2005; 1751:119–139.
   PubMed Web of Science ®Google Scholar
• Jorgensen L, Vermehren C, Bjerregaard S, Froekjaer S. Secondary structure alterations in insulin and growth hormone water-in-oil emulsions. Int. J. Pharm. 2003; 254: 7–10.
   PubMed Web of Science ®Google Scholar
• Jaganathan KS, Singh P, Prabhakaran D, Mishra V, Vyas SP. Development of a single-dose stabilized poly (D, L-lactic-co-glycolic acid) microspheres based vaccine against hepatitis-B. J. Pharm. Pharmacol. 2004; 56: 1243–125.
   PubMed Web of Science ®Google Scholar